Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies

Toxicology and Applied Pharmacology

Volumn 203, Issue 1, 2005, Pages 18-26

  Spiegelstein, Ofer ^a,i   Gould, Amy ^a,b   Wlodarczyk, Bogdan ^a   Tsie, Marlene ^a   Lu, Xiufen ^c   Le, Chris ^c   Troen, Aron ^d   Selhub, Jacob ^d   Piedrahita, Jorge A ^e   Salbaum, J Michael ^f,j   Kappen, Claudia ^f,j   Melnyk, Stepan ^h   James, Jill ^h   Finnell, Richard H ^a,g  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d TUFTS UNIVERSITY   (United States)

^e NORTH CAROLINA STATE UNIVERSITY   (United States)

^f MAYO CLINIC   (United States)

^g TEXAS A AND M UNIVERSITY   (United States)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

ⁱ Teva Pharmaceutical Industries   (Israel)

^j UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

more..

Author keywords

Arsenic; Biotransformation; Detoxification; Folbp1; Neural tube defects; RFC; Teratogenicity

Indexed keywords

ARSENATE SODIUM; FOLATE BINDING PROTEIN; REDUCED FOLATE CARRIER; S ADENOSYLHOMOCYSTEINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MODIFICATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; GENE DISRUPTION; GENE INACTIVATION; GENE LOCUS; GENOTYPE; HETEROZYGOTE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PRENATAL EXPOSURE; TRANSGENIC MOUSE; WILD TYPE;

EID: 13444282095     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.07.006     Document Type: Article

References (49)

1. A.C. Antony The biological chemistry of folate receptors Blood 79 1992 2807 2820
2. A.C. Antony Folate receptors Annu. Rev. Nutr. 16 1996 501 521
3. R.C. Barber, G.M. Show, E.J. Lammer, K.A. Greer, T.A. Biela, S.W. Lacey, C.R. Wasserman, and R.H. Finnell Lack of association between mutations in the folate receptor-alpha gene and spina bifida Am. J. Med. Genet. 76 1998 310 317
4. R.C. Barber, G.D. Bennett, K.A. Greer, and R.H. Finnell Expression patterns of folate binding proteins one and two in the developing mouse embryo Mol. Genet. Metab. 66 1999 31 39
5. R.J. Berry, Z. Li, J.D. Erickson, S. Li, C.A. Moore, H. Wang, J. Mulinare, P. Zhao, L.Y. Wong, J. Gindler, S.X. Hong, and A. Correa Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention N. Engl. J. Med. 341 1999 1485 1490
6. R.J. Berry, and Z. Li Folic acid alone prevents neural tube defects: evidence from the China study Epidemiology 13 2002 114 116
7. A.E. Czeizel, and I. Dudas Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation N. Engl. J. Med. 327 1992 1832 1835
8. J.M. DeSesso Teratogen update: inorganic arsenic Teratology 63 2001 170 173
9. P.C. Elwood Molecular cloning and characterization of the human folate binding protein cDNA from placenta and malignant tissue culture J. Biol. Chem. 264 1989 14893 14901
10. R.H. Finnell, W.M. Junker, L.K. Wadman, and R.M. Cabrera Gene expression profiling within the developing neural tube Neurochem. Res. 27 2002 1165 1180
11. R.H. Finnell, B. Wlodarczyk, O. Spiegelstein, A. Triplett, and J. Gelineau-vanWaes Folate transport abnormalities and congenital defects S. Milstein G. Kapatos R.A. Levine B. Shane Chemistry and Biology of Pteridines and Folates 2002 Kluwer Academic Publishers Norwich, MA 637 642
12. M.S. Golub, M.S. Macintosh, and N. Baumrind Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns J. Toxicol. Environ. Health, Part B Crit. Rev. 1 1998 199 241
13. F.H. Holson, J.M. Desesso, C.F. Jacobson, and C.F. Farr Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic Teratology 62 2000 51 71
14. M.J. Khoury, Q. Yang, M. Gwinn, J. Little, Dana, and W. Flanders An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions Genet. Med. 6 2004 38 47
15. X.C. Le, X. Lu, M. Ma, W.R. Cullen, V. Aposhian, and B. Zheng Speciation of key arsenic metabolic intermediates in human urine Anal. Chem. 72 2000 5172 5177
16. D.M. Maddox, A. Manlapat, P. Roon, P. Prasad, V. Ganapathy, and S.B. Smith Reduced folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart BioMed Central Dev. Biol. 3 2003 6 13
17. L.J. Martin, A.F. Machado, M.A. Loza, G.E. Mao, G.S. Lee, D.N. Hovland, R.M. Cantor, and M.D. Collins Effect of arsenite, maternal age, and embryonic sex on spina bifida, exencephaly and resorption rates in the Splotch mouse Birth Defects Res., Part A 67 2003 231 239
18. S. Melnyk, M. Pogribna, I.P. Pogribny, P. Yi, and S.J. James Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5′-phosphate concentrations Clin. Chem. 46 2000 265 272
19. M.M. Nelson, C.W. Asling, and H.M. Evans Production of multiple congenital abnormalities in young by maternal pteroylglutamic acid deficiency during gestation J. Nutr. 48 1952 61 80
20. M.M. Nelson Teratogenic effects of pteroylglutamic acid deficiency in the rat Ciba Found. Symp. Cong. 1960 134 157
21. J.A. Piedrahita, S.H. Zhang, J.R. Hagaman, P.M. Clark, and N. Maeda Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in mouse embryonic stem cells Proc. Natl. Acad. Sci. 89 1992 4471 4475
22. J.A. Piedrahita, B. Oetama, G.D. Bennett, J. van Waes, B.A. Kamen, J. Richardson, S.W. Lacey, R.G. Anderson, and R.H. Finnell Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development Nat. Genet. 23 1999 228 232
23. P.D. Prasad, S. Ramamoorthy, A.J. Moe, C.H. Smith, F.H. Leibach, and V. Ganapathy Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells Biochim. Biophys. Acta 1223 1994 71 75
24. P.L. Rady, S. Szucs, RK. Matalon, J. Grady, S.D. Hudnall, L.H. Kellner, and H. Nitowsky Genetic polymorphism (G80A) of reduced folate carrier gene in ethnic populations Mol. Genet. Metab. 73 2001 285 286
25. L.H. Reid, E.G. Shesely, H.S. Kim, and O. Smithies Cotransformation and gene targeting in mouse embryonic stem cells Mol. Cell. Biol. 11 1991 2769 2777
26. J.F. Ross, P.K. Chaudhuri, and M. Ratnam Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications Cancer 73 1994 2432 2443
27. H. Said Cell biology and regulation of the intestinal folate absorption process S. Milstein G. Kapatos R.A. Levine B. Shane Chemistry and Biology of Pteridines and Folates 2002 Kluwer Academic Publishers Norwich, MA 655 660
28. H. Saitsu, M. Oshibashi, H. Nakano, and K. Shiota Spatial and temporal expression of folate-binding protein 1 (Fbp1) is closely associated with anterior neural tube closure in mice Dev. Dyn. 226 2003 112 117
29. J. Selhub, and W.A. Franklin The folate-binding protein of rat kidney. Purification, properties, and cellular distribution J. Biol. Chem. 259 1984 6601 6606
30. SL. Shalat, D.B. Walker, and R.H. Finnell Role of arsenic as a reproductive toxin with particular attention to neural tube defects J. Toxicol. Environ. Health 48 1996 253 272
31. G.M. Shaw, E.J. Lammer, C.R. Wasserman, C.D. O'Malley, and M.M. Tolarova Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally Lancet 345 1995 393 396
32. G.M. Shaw, D. Schaffer, E. Velie, K.M. Morland, and J.A. Harris Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects Epidemiology 6 1995 219 226
33. G.M. Shaw, C.D. O'Malley, C.R. Wasserman, M.M. Tolarova, and E.J. Lammer Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring Am. J. Med. Genet. 59 1995 536 545
34. G.M. Shaw, R. Rozen, R.H. Finnell, C.R. Wasserman, and E.J. Lammer Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida Am. J. Epidemiol. 148 1998 30 37
35. F.M. Sirotnak, and B. Tolner Carrier-mediated membrane transport of folates in mammalian cells Annu. Rev. Nutr. 19 1999 91 122
36. A.H. Smith, C. Hopenhayn-Rich, M.N. Bates, H.M. Goeden, I. Hertz-Picciotto, H.M. Duggan, R. Wood, M.J. Kosnett, and M.T. Smith Cancer risks from arsenic in drinking water Environ. Health Perspect. 97 1992 259 267
37. G.D. Snell, E. Fekete, and K.P. Hummel The relation of mating, ovulation, and the estrus smears in the house mouse to the time of day Anat. Rec. 76 1948 30 54
38. O. Spiegelstein, X. Lu, X.C. Le, A. Troen, J. Selhub, S. Melnyk, S.J. James, and R.H. Finnell Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice Toxicol. Lett. 145 2003 167 174
39. O. Spiegelstein, M.Y. Merriweather, N.J. Wicker, and R.H. Finnell Valproate-induced neural tube defects in folate binding protein-2 (folbp2) knockout mice Birth Defects Res., Part A 67 2003 974 978
40. O. Spiegelstein, L.E. Mitchell, M.Y. Merriweather, N.J. Wicker, Q. Zhang, E.J. Lammer, and R.H. Finnell Embryonic development of folate binding protein-1 (Folbp1) knockout mice: effects of the chemical form, dose, and timing of maternal folate supplementation Dev. Dyn. 231 2004 221 231
41. L.S. Tang, and R.H. Finnell Neural and orofacial defects in Folbp1 knockout mice Birth Defects Res., Part A Clin. Mol. Teratol. 67 2003 209 218
42. M. Vahter Genetic polymorphisms in the biotransformation of inorganic arsenic and its role in toxicity Toxicol. Lett. 112-113 2000 209 217
43. M. Vahter, and J. Enval In vivo reduction of arsenate in mice and rabbits Environ. Res. 32 1983 14 24
44. M. Vahter, and E. Marafante Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit Toxicol. Lett. 37 1987 41 46
45. M. Vahter, and E. Marafante In vivo methylation and detoxification of arsenic P.J. Craig F. Glockling The Biological Alkylation of Heavy Elements 1988 Royal Society of Chemistry London 105
46. Y. Wang, R. Zhao, R.G. Russell, and D. Goldman Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis Biochim. Biophys. Acta 1513 2001 49 54
47. J. Warkany, and R.C. Nelson Appearance of skeletal abnormalities in the offspring of rats reared on a deficient diet Science 92 1940 383 384
48. J.G. Wilson Environment and Birth Defects 1973 Academic Press New York
49. B. Wlodarczyk, O. Spiegelstein, J. Gelineau van-Waes, R.L. Vorce, X. Lu, X.C. Le, and R.H. Finnell Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice Toxicol. Appl. Pharmacol. 177 2001 238 246